Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:23 pm Sale | 2026-06-30 | 13G | ALX ONCOLOGY HLDGS INC ALXO | TCG Crossover GP II, LLC | 5,655,487 4.200% | -7,356,362 (-56.54%) | Filing History |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | FIRST TRACKS BIOTHERAPEUTICS I TRAX | TCG Crossover GP II, LLC | 2,895,304 8.300% | 2,895,304 (New Position) | Filing History |
| 2026-08-14 4:20 pm Sale | 2026-06-30 | 13G | FULCRUM THERAPEUTICS INC FULC | TCG Crossover GP II, LLC | 0 0.000% | -5,250,000 (Position Closed) | Filing History |
| 2026-08-14 4:18 pm Sale | 2026-06-30 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,447,310 5.000% | -392,179 (-21.32%) | Filing History |
| 2026-08-14 4:13 pm Sale | 2026-06-30 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 10,147,867 7.000% | -1,449,870 (-12.50%) | Filing History |
| 2026-07-24 9:15 pm Sale | 2026-07-22 | 13G | SURROZEN INC SRZN | TCG Crossover GP II, LLC | 1,148,101 9.900% | -325,000 (-22.06%) | Filing History |
| 2026-06-11 7:02 pm Purchase | 2026-06-02 | 13G | ZAI LAB LTD ZLAB | TCG Crossover GP II, LLC | 59,130,750 5.300% | 59,130,750 (New Position) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,839,489 6.400% | 94,474 (+5.41%) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | TCG Crossover GP II, LLC | 5,250,000 7.900% | 250,000 (+5.00%) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | TCG Crossover GP II, LLC | 4,100,029 9.990% | 1,397,872 (+51.73%) | Filing History |
| 2026-05-15 4:25 pm Purchase | 2026-03-31 | 13G | SURROZEN INC SRZN | TCG Crossover GP II, LLC | 1,473,101 12.700% | 199,091 (+15.63%) | Filing History |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 11,597,737 8.100% | -1,924,102 (-14.23%) | Filing History |
| 2026-05-15 4:24 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | TCG Crossover GP II, LLC | 4,622,151 5.500% | 194,446 (+4.39%) | Filing History |
| 2026-05-12 6:09 pm Purchase | 2026-05-05 | 13G | AVALO THERAPEUTICS INC PAR AVTX | TCG Crossover GP II, LLC | 3,017,120 7.900% | 3,017,120 (New Position) | Filing History |
| 2026-05-12 6:06 pm Purchase | 2026-05-05 | 13G | AURA BIOSCIENCES INC AURA | TCG Crossover GP II, LLC | 9,533,333 9.900% | 9,533,333 (New Position) | Filing History |
| 2026-05-01 4:36 pm Purchase | 2026-04-24 | 13G | ALTIMMUNE INC ALT | TCG Crossover GP II, LLC | 20,000,000 9.800% | 20,000,000 (New Position) | Filing History |
| 2026-04-01 5:29 pm Purchase | 2026-03-30 | 13G | VOR BIOPHARMA INC VOR | TCG Crossover GP II, LLC | 5,673,078 10.500% | 5,673,078 (New Position) | Filing History |
| 2026-02-27 5:17 pm Purchase | 2026-02-12 | 13G | TECTONIC THERAPEUTIC INC TECX | TCG Crossover GP II, LLC | 1,169,760 6.200% | 1,169,760 (New Position) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-10-27 | 13G | ADC THERAPEUTICS SA SHS ADCT | TCG Crossover GP II, LLC | 11,390,175 9.200% | 11,390,175 (New Position) | Filing History |
| 2026-02-17 4:25 pm Unchanged | 2025-12-31 | 13G | EYEPOINT INC EYPT | TCG Crossover GP II, LLC | 3,572,335 4.300% | 0 (Unchanged) | Filing History |